{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:35:47Z","timestamp":1760549747991,"version":"3.28.0"},"reference-count":34,"publisher":"IEEE","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1109\/enbeng.2015.7088884","type":"proceedings-article","created":{"date-parts":[[2015,4,22]],"date-time":"2015-04-22T20:33:48Z","timestamp":1429734828000},"page":"1-6","source":"Crossref","is-referenced-by-count":11,"title":["PLGA nanoparticles for calcitriol delivery"],"prefix":"10.1109","author":[{"given":"M J","family":"Ramalho","sequence":"first","affiliation":[]},{"given":"J A","family":"Loureiro","sequence":"additional","affiliation":[]},{"given":"B","family":"Gomes","sequence":"additional","affiliation":[]},{"given":"M F","family":"Frasco","sequence":"additional","affiliation":[]},{"given":"M A N","family":"Coelho","sequence":"additional","affiliation":[]},{"given":"M C","family":"Pereira","sequence":"additional","affiliation":[]}],"member":"263","reference":[{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1997.479"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2013.11.014"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2010.01.001"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2006.09.017"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgh086"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1039\/c2cc32149a"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2217\/nnm.12.31"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2014.06.024"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-13-0502"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2013.11.086"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-010510-100611"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-010510-100611"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0b013e3181c51ee6"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2010.03.037"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3318"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2009.09.001"},{"journal-title":"Sustained-Release Injectable Drug Delivery","year":"2010","author":"rhee","key":"ref4"},{"key":"ref27","article-title":"Transferrin surface-modified PLGA nanoparticles-mediated delivery of a proteasome inhibitor to human pancreatic cancer cells","author":"frasco","year":"2014","journal-title":"Journal of Biomedical Materials Research"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2010.10.008"},{"journal-title":"A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy to Patients With Non-Small Cell Lung Cancer","year":"2013","author":"therapeutics","key":"ref6"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2009.02.002"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2008.04.042"},{"key":"ref8","article-title":"A Double-Blind, Randomised, Placebo-Controlled, Two-Phase Study (a Single Ascending Dose Phase Followed by a Proof of Concept Phase) to Assess the Safety","author":"flexion therapeutics","year":"2010","journal-title":"Efficacy and Pharmacokinetics of FX005 (50 50 PLGA) Microspheres for the Treatment of Pain in Osteoarthritis of the Knee"},{"journal-title":"A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) Administered to Patients With Metastatic Castration-Resistant Prostate Cancer","year":"2013","author":"therapeutics","key":"ref7"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2012.01.043"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2014.05.118"},{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2012.12.006"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-012-0949-4"},{"key":"ref22","first-page":"1206","article-title":"P-selectin expression in a metastatic pancreatic tumor cell line (SUIT-2)","volume":"57","author":"iwamura","year":"1997","journal-title":"Cancer Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1021\/jf204194z"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ifset.2007.07.005"},{"key":"ref23","first-page":"2235","article-title":"Correlation between VDR Expression and Antiproliferative Activity of Vitamin D3 Compounds in Combination with Cytostatics","volume":"25","author":"pelczynska","year":"2005","journal-title":"Anticancer Research"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S1734-1140(12)70901-5"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2006.06.023"}],"event":{"name":"2015 IEEE 4th Portuguese Meeting on Bioengineering (ENBENG)","start":{"date-parts":[[2015,2,26]]},"location":"Porto, Portugal","end":{"date-parts":[[2015,2,28]]}},"container-title":["2015 IEEE 4th Portuguese Meeting on Bioengineering (ENBENG)"],"original-title":[],"link":[{"URL":"http:\/\/xplorestaging.ieee.org\/ielx7\/7076899\/7088795\/07088884.pdf?arnumber=7088884","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T18:50:28Z","timestamp":1490381428000},"score":1,"resource":{"primary":{"URL":"http:\/\/ieeexplore.ieee.org\/document\/7088884\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":34,"URL":"https:\/\/doi.org\/10.1109\/enbeng.2015.7088884","relation":{},"subject":[],"published":{"date-parts":[[2015,2]]}}}